Skip to main content
. 2014 Dec 21;14:630. doi: 10.1186/s12913-014-0630-1

Table 2.

Effects of the LTCI program on the LoS (Difference-in-difference estimation)

Model 1 Model 2 Model 3 Model 4
LTCI users Level 1 Level 2 Level 3
Intercept 0.960*** (0.011) 0.989*** (0.010) 0.981*** (0.010) 0.965*** (0.010)
Treatment (ref: Control) 1.271*** (0.059) −8.349*** (0.130) −2.843*** (0.114) 0.108 (0.067)
2009-2008 (ref: 2008–2007) −0.028* (0.016) −0.018 (0.015) 0.002 (0.015) 0.062*** (0.015)
2010-2009 (ref: 2009–2008) −0.203*** (0.027) −0.178*** (0.025) −0.138*** (0.025) −0.034 (0.026)
Employee (ref: Self-employed) 0.045* (0.024) 0.023 (0.023) 0.034 (0.023) 0.026 (0.023)
NHI premium (ten thousand KRW) 0.013*** (0.001) 0.012*** (0.001) 0.013*** (0.001) 0.013*** (0.001)
Large city (ref: Non-large city) 0.104*** (0.031) 0.108*** (0.029) 0.102*** (0.029) 0.104*** (0.029)
Number of physician visits −0.038*** (0.000) −0.032*** (0.000) −0.033*** (0.000) −0.034*** (0.000)
Number of chronic diseases 2.268*** (0.006) 2.086*** (0.005) 2.090*** (0.005) 2.120*** (0.005)
Adj R-Square 0.014 0.013 0.013 0.013
Subjects size n = 11,626,010 n = 11,438,550 n = 11,447,639 n = 11,546,567

*significant at the 10% level, **significant at the 5% level, ***significant at the 1% level.

Notes: (Model 1) treatment group = LTCI users, control group = non-LTCI users; (Model 2) treatment group = LTCI users in level 1, control group = non-LTCI users; (Model 3) treatment group = LTCI users in level 2, control group = non-LTCI users; (Model 4) treatment group = LTCI users in level 3, control group = non-LTCI users.